[144] Adaptive Biotechnologies Corp SEC Filing

Rhea-AI Filing Summary

Harlan Robins reported multiple sales of Common Stock under Form 144, and lists restricted shares acquired as compensation.

The filing shows securities to be sold include 10,000 Common Stock shares acquired as Restricted Stock Units on 03/06/2023 as compensation. The sale activity includes multiple disposals on 12/03/2025, 12/04/2025, 01/06/2026, and early February–March 2026, including transactions of 27,212 shares on 12/03/2025 and 32,273 shares on 02/02/2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Comon Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	10000	161200	153981561	03/02/2026	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/06/2023	Acquired as compensation -- Restricted Stock Units	The Issuer			10000	03/06/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Harlan Robins 1165 Eastlake Avenue East Seattle WA 98109	Common Stock	01/06/2026	10000	164412
Harlan Robins 1165 Eastlake Avenue East Seattle WA 98109	Common Stock	02/02/2026	2395	44130.99
Harlan Robins 1165 Eastlake Avenue East Seattle WA 98109	Common Stock	12/03/2025	27212	506428.93
Harlan Robins 1165 Eastlake Avenue East Seattle WA 98109	Common Stock	12/04/2025	10000	166125
Harlan Robins 1165 Eastlake Avenue East Seattle WA 98109	Common Stock	02/02/2026	32273	600732.85
Harlan Robins 1165 Eastlake Avenue East Seattle WA 98109	Common Stock	02/03/2026	515	9960
Harlan Robins 1165 Eastlake Avenue East Seattle WA 98109	Common Stock	02/03/2026	7605	144288.14

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)